Overalla (N = 84) | Most Recent VL Suppressed (N = 61) | Most recent VL Not Suppressed (N = 23) | p valueb | |||
---|---|---|---|---|---|---|
N | n | (row %) | n | (row %) | ||
Sex | ||||||
Male | 53 | 38 | 72 | 15 | 28 | 1.00 |
Female | 31 | 23 | 74 | 8 | 26 | |
Race/ethnicity | ||||||
White non-Hispanic | 43 | 32 | 74 | 11 | 26 | 0.81 |
Black non-Hispanic | 4 | 3 | 75 | 1 | 25 | |
Hispanic/Latino | 33 | 23 | 70 | 10 | 30 | 0.63 |
Other/unknown | 4 | 3 | 75 | 1 | 25 | |
Age (as of 6/30/2018, years) | ||||||
20-29 | 24 | 14 | 58 | 10 | 42 | 0.10 |
30-39 | 33 | 25 | 76 | 8 | 24 | |
40-49 | 15 | 12 | 80 | 3 | 20 | |
50-59 | 7 | 5 | 71 | 2 | 29 | |
≥ 60 | 5 | 5 | 100 | 0 | 0 | |
Place of birth | ||||||
United States | 48 | 37 | 77 | 11 | 23 | 0.33 |
Puerto Rico | 18 | 13 | 72 | 5 | 28 | 1.00 |
Other | 3 | 2 | 67 | 1 | 33 | |
Unknown | 15 | 9 | 60 | 6 | 40 | 0.34 |
HIV exposure risk | ||||||
Heterosexual only | 12 | 10 | 83 | 2 | 17 | 0.50 |
IDU | 67 | 47 | 70 | 20 | 30 | 0.38 |
MSM/IDU | 1 | 0 | 0 | 1 | 100 | |
Unknown/not documented | 4 | 4 | 100 | 0 | 0 | 0.57 |
Year HIV diagnosis | ||||||
Before and including 2016 c | 29 | 28 | 97 | 1 | 3 | < 0.0001 |
2017-2018 | 55 | 33 | 60 | 22 | 40 | |
Health insurance coverage | ||||||
Medicare | 9 | 7 | 78 | 2 | 22 | 1.00 |
Medicaid | 69 | 50 | 72 | 19 | 28 | |
Medicare/Medicaid | 1 | 0 | 0 | 1 | 100 | |
Private health insurance | 1 | 1 | 100 | 0 | 0 | |
None, self-pay | 4 | 3 | 75 | 1 | 25 | |
Incarceration during the review period | ||||||
Yes | 19 | 15 | 79 | 4 | 21 | 0.57 |
No | 65 | 46 | 71 | 19 | 29 | |
Homelessness during the review period | ||||||
Yes | 63 | 45 | 71 | 18 | 29 | 0.78 |
No | 18 | 14 | 78 | 4 | 22 | |
Not documented | 3 | 2 | 67 | 1 | 33 | |
Hospitalizations during the review period | ||||||
Yes | 49 | 36 | 73 | 13 | 27 | 1.00 |
No | 35 | 25 | 71 | 10 | 29 | |
Medication assisted treatment prescribed during review periodd | ||||||
Yes | 50 | 37 | 74 | 13 | 26 | 0.81 |
No | 34 | 24 | 71 | 10 | 29 | |
ART prescribed during review period | ||||||
Yes | 68 | 54 | 79 | 14 | 21 | 0.01 |
No | 16 | 7 | 44 | 9 | 56 | |
Substance use during review period (not mutually exclusive) | n = 83 | n = 60 | n = 23 | |||
Active use in review period | 59 | 40 | 68 | 19 | 32 | 0.18 |
History of use/inactive in review period | 8 | 6 | 75 | 2 | 25 | |
History of use/inactive in review period, on suboxone | 11 | 9 | 82 | 2 | 18 | |
No history | 5 | 5 | 100 | 0 | 0 | |
Treatment for drug and alcohol use (not mutually exclusive) | n = 59 | n = 40 | n = 19 | |||
Medication assisted treatmentd | 38 | 27 | 71 | 11 | 29 | 0.56 |
In treatment, another modalitye | 23 | 13 | 57 | 10 | 43 | 0.16 |
Counseled by provider | 13 | 8 | 62 | 5 | 38 | |
No action indicated | 3 | 2 | 67 | 1 | 33 | |
In treatment, another modality (not mutually exclusive) | n = 23 | n = 13 | n = 10 | |||
Counseling | 9 | 4 | 44 | 5 | 56 | 0.42 |
12-step program | 3 | 2 | 67 | 1 | 33 | |
Halfway/sober house | 9 | 7 | 78 | 2 | 22 | 0.20 |
Other | 10 | 4 | 40 | 6 | 60 |